The Cottage Surgery is a COVID vaccination site for Moderna Bivalent, Astra Zeneca, Pfizer and Novavax.
- please read the information below and review the relevant video on Astra Zeneca or Pfizer/Moderna mRNA COVID vaccines.
- Novavax vaccine is approved for patients over 12 years as a primary vaccination or as a booster. Please register your interest by phoning the surgery. For more information re Novavax, please read: Information on Novavax Vaccine and After your Novavax Vaccine
- please print and complete the COVID vaccination consent form to bring to the vaccination appointment. If the form raises any questions, please make a telephone appointment to discuss with your doctor at The Cottage/Corner, prior to vaccination. Vaccination will NOT proceed until these have been done.
- Flu vaccinations can be given at the same time as your COVID vaccine – please ask at the time of booking if you would like a flu vaccine also.
Vaccination clinics run from the rear of The Cottage Surgery with short vaccination only appointments. Please review the information below and complete the pre-vaccination questionnaire. If you have any questions , please make an telephone appointment with your doctor before attending the vaccination clinic as there will not be time to answer detailed questions at the clinic visit and you may miss your vaccination time slot. The vaccination clinic is only for people ready to be vaccinated. There will be a cohort of patients being vaccinated by a nurse, and the clinic will be overseen by a doctor.
Please print and complete the COVID vaccination consent form below, and bring with you when attending for vaccination. There are copies which can be collected from us prior to the day of vaccination if you do not have a printer.
Please watch the brief video relevant to your vaccination below:
Video : COVID vaccine Booster dose
Video : 1st dose Pfizer vaccination
Video : 2nd dose Pfizer vaccination
Video : 1st dose AstraZeneca vaccination
Video : 2nd dose AstraZeneca vaccination
Please bring your mask and maintain 1.5 m distancing.
Please be aware that the vaccination clinic may be outdoors in tents, so bring appropriate clothing for the weather.
To avoid overcrowding, please come alone or if needed bring 1 support person (eg a parent of a child).
If you are unwell or or unable to attend the appointment please call us so that the appointment slot can be offered to another patient.
The vaccine stimulates the body’s immune system to produce antibodies against the virus. None of the ingredients can cause COVID-19 or any other infection.
The vaccine will be injected into your upper arm – please wear loose clothing which can expose your arm easily. As with any vaccine it may not protect everyone. It is not yet known how long the vaccine protection will last.
Side Effects usually are mild to moderate and resolve within a few days. These can include:
Commonly: Tenderness, warmth, redness and itch at the injection site.
Headache, fatigue, muscle aches, joint pains, fever, nausea.
Uncommonly: Fainting, dizziness.
Very rarely: Allergic reaction including anaphylaxis,
The AstraZeneca vaccine may very very rarely cause blood clots.
The Pfizer vaccine may very very rarely cause an inflammation of the heart and Bells palsy (a weakness in the facial nerve)
Pfizer vaccinations are approved for children 5-11 years with a second dose 8 weeks after the first.
3rd doses are recommended for people aged 16 years and older, 3 months after their 2nd dose
4th doses are available for those aged 30 years and above, and also recommended for people living in disability or nursing home care, 3 months after their 3rd dose.
In addition to anyone aged 30 and above, people aged 16–29 are eligible for a 4th dose if they have conditions including:
- Cancer, with examples as follows: Non-haematological cancer including those diagnosed within the past five years or on chemotherapy, radiotherapy, immunotherapy or targeted anti-cancer therapy (active treatment or recently completed) or with advanced disease regardless of treatment. Survivors of childhood cancer
- Chronic inflammatory conditions requiring medical treatment with disease modifying antirheumatic drugs (DMARDs) or immunesuppressive or immunomodulatory therapies with examples as follows: Systemic lupus erythematosus, rheumatoid arthritis, Crohn’s disease, ulcerative colitis, and similar who are being treated
- Chronic lung disease with examples as follows: Chronic obstructive pulmonary disease, cystic fibrosis, interstitial lung disease and severe asthma (defined as requiring frequent hospital visits or the use of multiple medications).
- Chronic liver disease with examples as follows: Cirrhosis, autoimmune hepatitis, nonalcoholic fatty liver disease, alcoholic liver disease
- Severe chronic kidney disease (stage 4 or 5)
- Chronic neurological disease with examples as follows: Stroke, neurodegenerative disease (eg dementia, motor neurone disease, Parkinson’s disease), myasthenia gravis, multiple sclerosis, cerebral palsy, myopathies, paralytic syndromes, epilepsy
- Diabetes mellitus requiring medication
- Chronic cardiac disease with examples as follows: Ischaemic heart disease, valvular heart disease, congestive cardiac failure, cardiomyopathies, poorly controlled hypertension, pulmonary hypertension, complex congenital heart disease
- People with disability with significant or complex health needs or multiple comorbidities which increase the risk of poor outcome from COVID-19, particularly those with trisomy 21 (Down Syndrome) or complex multisystem disorders
- Severe obesity with BMI ≥ 40 kg/m2
- Severe underweight with BMI < 16.5 kg/m2
ATAGI said the list is not exhaustive, and that ‘providers may include individuals with conditions similar to those listed below, based on clinical judgment’.
Boosters are also approved from June 2022 for adolescents aged 12-15 years who have completed a primary course of vaccination 3 or more months ago:
- those who are severely immunocompromised
- those who have a disability with significant or complex health needs
- those who have complex and/or multiple health conditions that increase the risk of severe COVID-19
The group also reiterated that the additional winter doses should be delayed three months after a confirmed COVID-19 infection has cleared.